Global HER2 Antibody Market Growth (Status and Outlook) 2025-2031

Global HER2 Antibody Market Growth (Status and Outlook) 2025-2031

The global HER2 Antibody market size is predicted to grow from US$ 15770 million in 2025 to US$ 24380 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.

Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.

LPI (LP Information)' newest research report, the “HER2 Antibody Industry Forecast” looks at past sales and reviews total world HER2 Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected HER2 Antibody sales for 2025 through 2031. With HER2 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Antibody industry.

This Insight Report provides a comprehensive analysis of the global HER2 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HER2 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus

Segmentation by Application:
Hospital
Medical Center

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne

Please note: The report will take approximately 2 business days to prepare and deliver.